Structures by: Stibrany R. T.
Total: 60
2
C19H20N4O
Macromolecules (2003) 36, 23 8584
a=9.6500(19)Å b=12.945(3)Å c=13.570(3)Å
α=90.00° β=90.00° γ=90.00°
3b
C27H36N4
Macromolecules (2003) 36, 23 8584
a=10.2808(5)Å b=19.4888(10)Å c=13.1128(6)Å
α=90.00° β=100.391(4)° γ=90.00°
5-H2O
C19H20Cl2CuN4O,H2O
Macromolecules (2003) 36, 23 8584
a=9.1950(7)Å b=10.6666(9)Å c=11.7048(10)Å
α=68.734(6)° β=72.373(7)° γ=76.602(6)°
5
C19H20Cl2CuN4O
Macromolecules (2003) 36, 23 8584
a=14.0360(10)Å b=16.2580(10)Å c=17.0120(10)Å
α=90° β=90° γ=90°
6b
C27H36Cl2CuN4
Macromolecules (2003) 36, 23 8584
a=13.540(2)Å b=14.597(2)Å c=13.972(2)Å
α=90.00° β=97.63(2)° γ=90.00°
[(rac 2,2'-bis[2-(1-ethyl benzimidazol-2-yl)]biphenyl)copper(II) dichloride] 1,2-dichlorobenzene
C30H26Cl2CuN4,C6H4Cl2
Macromolecules (2003) 36, 23 8584
a=16.250(4)Å b=15.629(8)Å c=14.067(5)Å
α=90.00(3)° β=109.01(3)° γ=90.00(3)°
1,3-diethylbenzimidazolium iodide
C11H15N2,I
Acta Crystallographica Section E (2004) 60, 1 o28-o30
a=11.2578(5)Å b=14.6014(7)Å c=15.1903(5)Å
α=90.00° β=90.212(3)° γ=90.00°
Rac-ammonium trans-2-carboxycyclohexanecarboxylate
C8H11O4,H4N
Acta Crystallographica Section E (2004) 60, 6 o1012-o1014
a=15.712(7)Å b=6.141(3)Å c=10.464(5)Å
α=90.00° β=104.96(4)° γ=90.00°
Bis[(S,S)-1,2-dimethoxy-1,2-bis(1-methyl-1H-benzimidazol-2- yl)ethane]palladium(II) dichloride
C40H44N8O4Pd2,2Cl
Acta Crystallographica Section E (2005) 61, 10 m1991-m1994
a=13.0985(4)Å b=10.7801(4)Å c=17.0783(6)Å
α=90.00° β=102.440(3)° γ=90.00°
Κ^2^N^13^,N^43^Hydro-rac-2,2-bis[2-(1-propyl benzimidazol-2yl)]biphenyl trifluoromethanesulfonate
C32H31N4,C1F3O3S1
Acta Crystallographica Section E (2002) 58, 10 o1142-o1144
a=14.383(3)Å b=14.217(3)Å c=15.252(5)Å
α=90.00° β=92.850(10)° γ=90.00°
1-Benzyl-4,5-diphenyl-3-vinylimidazolium bromide
C24H21N21,Br1
Acta Crystallographica Section E (2002) 58, 8 o848-o850
a=10.883(2)Å b=9.440(2)Å c=11.210(2)Å
α=90.00° β=111.070(10)° γ=90.00°
(S,S)-1,2-bis(1-hydrobenzimidazol-2-yl)-1,2-ethanediol
C20H22N4O2
Acta Crystallographica Section E (2003) 59, 10 o1448-o1450
a=6.7980(6)Å b=10.9084(9)Å c=25.331(2)Å
α=90.00° β=90.00° γ=90.00°
Rac-[2,2-Bis(1-ethylbenzimidazol-2-yl-κN^3^)biphenyl]dichloronickel(II)
C30H26Cl2N4Ni
Acta Crystallographica Section E (2004) 60, 2 m188-m189
a=9.1464(5)Å b=18.6955(10)Å c=16.4401(10)Å
α=90.00° β=95.806(4)° γ=90.00°
2-Phenylimidazoline
C9H10N2
Acta Crystallographica Section E (2004) 60, 4 o527-o529
a=13.4996(6)Å b=5.1922(2)Å c=22.4019(13)Å
α=90.00° β=95.880(4)° γ=90.00°
5,6-Dichloro-1-propyl-1H-benzimidazole
C10H10Cl2N2
Acta Crystallographica Section E (2004) 60, 9 o1603-o1605
a=6.2342(6)Å b=9.4516(8)Å c=9.8012(9)Å
α=104.207(7)° β=91.138(8)° γ=101.849(7)°
Naphthimidazole
C11H8N2
Acta Crystallographica Section E (2004) 60, 9 o1648-o1651
a=9.4503(6)Å b=16.3882(8)Å c=11.4770(9)Å
α=90.00° β=110.502(4)° γ=90.00°
(E)-1,2-bis(1-ethylbenzimidazol-2-yl)ethene dihydrate
C20H20N4,2H2O
Acta Crystallographica Section E (2006) 62, 2 o828-o830
a=11.0314(8)Å b=4.8234(3)Å c=17.8657(15)Å
α=90.00° β=102.498(6)° γ=90.00°
Trans-1,2-Bis(1-methylbenzimidazol-2-yl)cyclohexane monohydrate
C22H24N4,H2O
Acta Crystallographica Section E (2006) 62, 1 o140-o142
a=9.6596(7)Å b=14.5552(11)Å c=13.5470(10)Å
α=90.00° β=90.00° γ=90.00°
Diphenylimidazole
C15H12N2
Acta Crystallographica Section E (2004) 60, 7 o1182-o1184
a=13.3716(7)Å b=13.0984(8)Å c=14.6909(12)Å
α=90.00° β=110.343(4)° γ=90.00°
2,2'-bis(1-ethylbenzimidazol-2-yl)biphenyl
C30H26N4
Acta Crystallographica Section E (2003) 59, 5 o693-o695
a=12.0156(6)Å b=10.7001(6)Å c=18.6280(9)Å
α=90.00° β=95.177(4)° γ=90.00°
Rac-bis[(1S,2S)-trans-3,3-(1,2-cyclohexanediyldinitrilo)bis- (2-methylpropane-2-thiolato)]-1κ^4^N^1^,N^1'^,S^1^,S^1'^;- 2κ^4^N^2^,N^2'^,S^2^,S^2'^;3κ^2^S^1^,S^2'^;4κ^2^S^1'^,S^2^;- 5κ^2^S^1'^,S^2'^-trichloro-3κCl,4κCl,5κCl-tricopper(I)- dinickel(II) bis(dimethylformamide) solvate
C28H56Cl3Cu3N4Ni2S4,2C3H7NO
Acta Crystallographica Section E (2003) 59, 8 m630-m632
a=11.874(3)Å b=20.058(4)Å c=21.348(5)Å
α=90.00° β=100.480(10)° γ=90.00°
Bis[(S,S)-1,2-dimethoxy-1,2-bis(1-methyl-1H-benzimidazol-2-yl)ethane]copper(II) bis(tetrafluoroborate) acetonitrile disolvate
C40H44CuN8O42,2BF4,2C2H3N
Acta Crystallographica Section E (2004) 60, 8 m1147-m1150
a=9.2286(5)Å b=11.4896(6)Å c=12.0277(7)Å
α=80.517(4)° β=82.803(4)° γ=73.690(4)°
Rac-bis[2,2'-bis(1-ethyl-1H-benzimidazol-2-yl)biphenyl]copper(I) trifluoromethanesulfonate toluene solvate dihydrate
C60H52CuN8,CF3SO3,C7H8,H4O2
Acta Crystallographica Section E (2004) 60, 12 m1836-m1840
a=11.1715(7)Å b=24.1173(10)Å c=23.0286(9)Å
α=90.00° β=95.190(4)° γ=90.00°
Μ-oxalato-1κ^2^O^1^,O^2^:2κ^2^O^1^,O^2'^-bis[bis(1-benzyl-1H-pyrazole- κN^2^)(trifluoromethanesulfonato-κO)copper(II)]
C44H40Cu2F6N8O10S2
Acta Crystallographica Section E (2005) 61, 10 m1904-m1906
a=10.8432(5)Å b=11.0190(5)Å c=11.4895(5)Å
α=87.389(4)° β=75.577(4)° γ=65.539(4)°
C16H28Cl2Cu1N6O8
C16H28Cl2Cu1N6O8
Acta Crystallographica Section C (1993) 49, 9 1561-1564
a=10.5490(10)Å b=9.2465(9)Å c=25.256(2)Å
α=90.° β=101.420(10)° γ=90.°
Bis[S,S(-)-trans-3,3'-(1,2-cyclohexandiyldinitrilo)-bis(2-methylpropane-2- thialato)nickel(II)] [(μ-iodocopper(I)-κ^2^S^1^,S^2'^)(μ-iodocopper(I)-κ^2^S^2^,S^1'^)(μ- iodocopper(I)-κ^2^S^2^,S^2'^)].diacetonitrile
C28H56Cu3I3N4Ni2S4,C4H6N2
Acta Crystallographica Section C (1996) 52, 11 2731-2734
a=12.837(3)Å b=18.081(4)Å c=11.747(4)Å
α=96.49(2)° β=106.84(3)° γ=107.77(3)°
Rac-(acetonitrile)[2,2'-bis(1-propyl-1H-benzimidazol-2-yl)biphenyl]copper(I) bis(acetonitrile)[2,2'-bis(1-propyl-1H-benzimidazol-2-yl)biphenyl]copper(I) bis(perchlorate)
C36H36CuN6,C34H33CuN5,2ClO4
Acta Crystallographica Section E (2006) 62, 12 m3425-m3428
a=8.8593(15)Å b=17.407(3)Å c=22.760(4)Å
α=71.424(3)° β=87.901(3)° γ=88.588(3)°
C9H14N11,C18H1B1F15O11
C9H14N11,C18H1B1F15O11
Acta Crystallographica Section C (2001) 57, 5 644-645
a=10.552(5)Å b=15.287(2)Å c=16.072(9)Å
α=90° β=96.60(5)° γ=90°
3-ethyl-2-[(E)-2-(1-ethylbenzimidazol-2-yl)ethenyl]benzimidazol-1-ium perchlorate
C20H21N4,ClO4
Acta Crystallographica Section C (2005) 61, 6 o354-o357
a=14.3810(5)Å b=8.3007(3)Å c=16.4788(6)Å
α=90.00° β=91.561(3)° γ=90.00°
(E)-1,2-bis(1-methylbenzimidazol-2-yl)ethene
C18H16N4
Acta Crystallographica Section C (2005) 61, 6 o354-o357
a=6.2517(2)Å b=12.0363(5)Å c=9.9464(3)Å
α=90.00° β=102.927(3)° γ=90.00°
(E)-1,2-bis(1-ethylbenzimidazol-2-yl)ethene
C20H20N4
Acta Crystallographica Section C (2005) 61, 6 o354-o357
a=5.1789(4)Å b=11.2713(8)Å c=14.4525(9)Å
α=90.00° β=94.905(5)° γ=90.00°
3,6-dibromo-1-<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole hemihydrate
C15H8Br2N2,0.5H2O
Acta Crystallographica Section C (2009) 65, 8 o406-o409
a=8.415(2)Å b=10.139(2)Å c=17.227(4)Å
α=101.683(4)° β=101.398(5)° γ=104.109(5)°
1-<i>H</i>-phenanthro[9,10-<i>d</i>]imidazole
C15H10N2
Acta Crystallographica Section C (2009) 65, 8 o406-o409
a=19.559(3)Å b=5.2321(8)Å c=19.871(3)Å
α=90.00° β=90.00° γ=90.00°
Κ^2^N^3^:N^3^]dicopper(I)]-μ-(<i>E</i>)-1,2-bis(1-ethyl-1H-benzimidazol-2-yl)ethene-κ^2^N^3^:N^3'^] bis(perchlorate) acetonitrile disolvate]
C30H30CuN6,ClO4,C2H3N
Acta Crystallographica Section C (2008) 64, 5 m213-m216
a=21.834(6)Å b=12.948(4)Å c=23.502(10)Å
α=90.00° β=97.039(4)° γ=90.00°
C16H28Cl2N6O8Zn1
C16H28Cl2N6O8Zn1
Acta Crystallographica Section C (1993) 49, 9 1561-1564
a=10.7080(10)Å b=9.229(2)Å c=25.205(2)Å
α=90.° β=101.867(8)° γ=90.°
Dibromido[1,1'-dibutyl-2,2'-(pentane-1,1-diyl)di-1<i>H</i>- benzimidazole]copper(II)
C27H36Br2CuN4
Acta Crystallographica Section E (2010) 66, 7 m767-m768
a=13.521(2)Å b=14.604(3)Å c=13.881(2)Å
α=90.00° β=96.636(3)° γ=90.00°
(<i>E</i>)-1,2-Bis(1-propyl-5,6-dimethyl-1<i>H</i>-benzimidazol-2-yl)ethene
C26H32N4
Acta Crystallographica Section E (2010) 66, 3 o585
a=12.7822(15)Å b=10.4802(12)Å c=16.5944(19)Å
α=90.00° β=100.284(2)° γ=90.00°
{Bis[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]borato}{tris[5-methyl-3- (trifluoromethyl)pyrazol-1-yl]borato}cobalt(II)
C25H23B2CoF15N10
Acta Crystallographica Section E (2010) 66, 5 m506-m507
a=10.8195(16)Å b=16.559(2)Å c=18.687(3)Å
α=90.00° β=98.408(3)° γ=90.00°
{Bis[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]borato}{tris[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]borato}cobalt(II)
C25H23B2CoF15N10
Acta Crystallographica Section E (2011) 67, 7 m911-m912
a=18.593(2)Å b=12.1167(13)Å c=30.720(3)Å
α=90.00° β=102.721(2)° γ=90.00°
<i>rac</i>-Dichlorido[3-ethoxy-3-(1-ethyl-1<i>H</i>-benzimidazol-2-yl)-2,3- dihydro-1<i>H</i>-pyrrolo[1,2-<i>a</i>]benzimidazole]copper(II)
C21H22Cl2CuN4O
Acta Crystallographica Section E (2013) 69, 2 m92-m93
a=8.9409(17)Å b=9.5209(18)Å c=14.323(3)Å
α=106.973(4)° β=92.373(4)° γ=113.778(4)°
Ethyl 7-oxo-7<i>H</i>-benzo[<i>de</i>]imidazo[5,1-<i>a</i>]isoquinoline-11-carboxylate--trifluoroacetic acid (1/1)
C17H12N2O3,C2HF3O2
Acta Crystallographica Section E (2013) 69, 6 o977-o978
a=7.642(3)Å b=8.111(4)Å c=14.043(6)Å
α=97.539(8)° β=98.055(8)° γ=92.695(8)°
Di[υ~2~-(N,N-bis(2-mercaptoκ^1^Ni',κ^1^Ni''-2-methylprop-1-yl) -1S*κ^1^Ni',3R*κ^1^Ni''-cyclohexanediamine)nickel(II)] 2 dimethylformamide solvate
C32H64N4Ni2S4,2(C3H7NO)
Inorganic Chemistry (2005) 44, 8234-8242
a=10.435(7)Å b=10.7020(10)Å c=12.251(3)Å
α=94.870(10)° β=111.170(10)° γ=107.785(7)°
N,N'-bis(1-carboxy-2-mercaptoethyl)-1,2-diaminoethanenickel(II) N,N'-1,3-diammoniumpropane 3 water solvate
C8H12N2NiO4S2,C3H12N2,3(O)
Inorganic Chemistry (2005) 44, 8234-8242
a=8.0080(16)Å b=13.371(3)Å c=18.151(4)Å
α=90.00° β=90.00° γ=90.00°
N,N'-bis-(2-methyl-2-mercapto-prop-1-yl)-1,3-diamino -2,2-dimethyl-propanenickel(II)
C13H28N2NiS2
Inorganic Chemistry (2005) 44, 8234-8242
a=11.852(2)Å b=14.115(3)Å c=10.878(2)Å
α=90.00° β=111.50(3)° γ=90.00°
N,N'-bis-(2-methyl-2-mercapto-prop-1-yl)-1,3-diamino -2,2-dimethyl-propanenickel(II)
C13H28N2NiS2
Inorganic Chemistry (2005) 44, 8234-8242
a=11.7710(15)Å b=14.0419(17)Å c=10.8293(13)Å
α=90.00° β=110.946(4)° γ=90.00°
2
2(C7H20N5O4Ru),C3H7NO,2(O4S)
Inorganic Chemistry (2008) 47, 9813-9827
a=7.2458(5)Å b=9.6065(6)Å c=12.8276(8)Å
α=80.3290(10)° β=88.7540(10)° γ=85.5150(10)°
3
C7H20N5O4Ru,O4S,2(H2O)
Inorganic Chemistry (2008) 47, 9813-9827
a=15.4850(8)Å b=7.6969(4)Å c=14.9386(8)Å
α=90.00° β=107.845(1)° γ=90.00°
6
C8H25N9O2Ru,ZnCl4,Cl
Inorganic Chemistry (2008) 47, 9813-9827
a=7.4212(3)Å b=8.8688(3)Å c=31.3964(12)Å
α=90.00° β=90.00° γ=90.00°
2
2(C7H20N5O4Ru),C3H7NO,2(O4S)
Inorganic Chemistry (2008) 47, 9813-9827
a=9.6174(8)Å b=12.864(2)Å c=7.3320(10)Å
α=90.970(10)° β=93.920(10)° γ=80.923(8)°
3
C7H20N5O4Ru,O4S,2(H2O)
Inorganic Chemistry (2008) 47, 9813-9827
a=15.4410(10)Å b=7.7410(7)Å c=15.0160(10)Å
α=90.000(10)° β=107.820(10)° γ=90.000(10)°
Rac-2
C14H28CuN2S2
Inorganic Chemistry (2002) 41, 5203-5215
a=10.162(2)Å b=16.221(3)Å c=10.3320(10)Å
α=90.00° β=94.240(10)° γ=90.00°
Rac-5.2ClO4
C25H54Cl2Cu2N6O8S2
Inorganic Chemistry (2002) 41, 5203-5215
a=15.147(3)Å b=15.324(3)Å c=16.858(3)Å
α=90.00° β=106.492(3)° γ=90.00°
Rac-6.2DMF
C34H70Cl3Cu5N6O2S4
Inorganic Chemistry (2002) 41, 5203-5215
a=11.9583(15)Å b=20.162(3)Å c=21.430(3)Å
α=90.00° β=99.898(2)° γ=90.00°
R,R-7Cl.solvate
C52H84Cl2Cu5N6.5O4S6
Inorganic Chemistry (2002) 41, 5203-5215
a=19.312(2)Å b=19.312(2)Å c=19.312(2)Å
α=90.00° β=90.00° γ=90.00°
Bis([bis(3,5-dimethylpyrazol-1-yl) (dimethylamino)methane]copper(II)perchlorate Bis(dichloromethane)
C28H46Cl6CuN10O8
Inorganic Chemistry (1999) 38, 132-135
a=26.278(5)Å b=8.835(2)Å c=20.655(4)Å
α=90.00° β=120.73(3)° γ=90.00°
6S^*^,7S^*^,16S^*^,17S^*^-3,3,10,10,13,13,20,20-Octamethyl- diperhydrobenzo-[f,p]-1,2,10,12-tetrathia-5,8,15,18- tetraaza-cycloicosane
C28H56N4S4
Inorganic Chemistry (2000) 39, 4950-4961
a=12.0309(16)Å b=9.7063(18)Å c=28.769(3)Å
α=90.000(12)° β=93.074(10)° γ=90.000(13)°
[Ni~2~(rac-9)I~2~(CH~3~CN)~2~]^2+^2I^-^
C32H62I4N6Ni2S4
Inorganic Chemistry (2000) 39, 4950-4961
a=10.119(3)Å b=12.288(4)Å c=10.121(3)Å
α=104.68(2)° β=98.39(2)° γ=104.75(2)°
5
C42H42N6
Inorganic Chemistry (2006) 45, 9713-9720
a=24.5701(11)Å b=24.5701(11)Å c=10.1453(8)Å
α=90.00° β=90.00° γ=120.00°
[Cu^I^4(trif)]^.^C6 H14
C36H30CuN6,CF3O3S
Inorganic Chemistry (2006) 45, 9713-9720
a=12.7358(4)Å b=12.7358(4)Å c=44.271(3)Å
α=90.00° β=90.00° γ=120.00°
[Ag^I^(trif)]^.^0.5(C3 H6 O)^.^0.5(C4 H10 O)
C36H30AgN6,CF3O3S
Inorganic Chemistry (2006) 45, 9713-9720
a=13.1505(4)Å b=13.1505(4)Å c=44.152(3)Å
α=90.00° β=90.00° γ=120.00°